|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/14 | |
| C07D 491/14 | |||
| C07D 495/14 | |||
| C07D 498/14 | |||
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Number of the document | 2813506 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14177962.9 |
| Date of filing the European patent application | 2011-12-15 | |
| (97) | Date of publication of the European application | 2014-12-17 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 423694 P | 2010-12-16 | US |
| (72) |
Dotson, Jennafer, US
Heald, Robert Andrew, GB
Heffron, Timothy, US
Jones, Graham Elgin, GB
Krintel, Sussie Lerche, GB
McLean, Neville James, GB
Ndubaku, Chudi, US
Olivero, Alan G., US
Salphati, Laurent, US
Wang, Lan, US
Wei, BinQing, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | Tricyclic PI3K inhibitor compounds and methods of use |
| Tricyclic PI3K inhibitor compounds and methods of use |